Computed tomography findings of sorafenib‐treated hepatic tumors in patients with advanced hepatocellular carcinoma

Abstract

In patients with advanced HCC who were treated by sorafenib, the size of the hepatic tumors was not significantly reduced. However, the median survival was better for the patients with the response of stable disease. The attenuation values of the tumors became lower after treatment, as compared to the baseline CT scans.